Co-administration with CYP3A4 inhibitors

Lumeva · Episodic migraine

MI-2026-0619UrgentSentBreached

LOLuis OrtegaMSL, Neurology (Iberia)

Received: 14 Sept 2026, 15:59 UTC
Channel: Web portal
Requestor type: HCP
Country / region / team: Germany · Europe · MI Europe
Category: Drug interaction
Response type: Standard response
Owner: LOLuis Ortega
Due: 16 Sept 2026, 15:59 UTC
Responded: 16 Sept 2026, 18:59 UTC
Quality review: Not required
Related insight: —
Related standard response: SR-LMV-007 · Co-administration with CYP3A4 inhibitors (v3)

Workflow

12-stage inquiry workflow (PRD §16). Advancing records an audit event.

Current stageSentDemo action — not persisted

Urgent: 48 h target · Routine 120 h / Urgent 48 h / Critical 24 h

SLA hours

Elapsed

51 h

to response

Breached by

3 h

100%

14 Sept 2026, 15:59 UTC
Received via Web portal
HCP · Germany
14 Sept 2026, 15:59 UTC
Triage and assignment
Urgency Urgent · assigned to MI Europe
16 Sept 2026, 15:59 UTC
SLA due (48 h)
16 Sept 2026, 18:59 UTC
Response sent
Standard response · quality review not required

Demo — drafts are not persisted

AI suggestion available for non-safety inquiries

Draft response

No audit events for this record

Create, update, approve and export events appear here with user, timestamp, previous and new values.

Data lineage: MI inquiry platform (IRMS, INT-05) · received 14 Sept 2026 · hourly sync.